
==== Front
ACS OmegaACS OmegaaoacsodfACS Omega2470-1343American Chemical Society 3145874810.1021/acsomega.8b00464ArticleHOAc-Mediated Domino Diels–Alder Reaction for
Synthesis of Spiro[cyclohexane-1,3′-indolines]
in Ionic Liquid [Bmim]Br Yang Ren-Yin Sun Jing Yan Chao-Guo *College of Chemistry, Chemical
Engineering, Yangzhou University, Yangzhou 225002, China* E-mail: cgyan@yzu.edu.cn.21 05 2018 31 05 2018 3 5 5406 5416 13 03 2018 30 04 2018 Copyright © 2018 American Chemical Society2018American Chemical SocietyThis is an open access article published under an ACS AuthorChoice License, which permits copying and redistribution of the article or any adaptations for non-commercial purposes.

An efficient and
diastereoselective synthetic protocol for the
construction of spiro[cyclohexane-1,3′-indolin]-3-en-2′-ones
and spiro[cyclohexane-1,2′-inden]-3-ene-1′,3′-diones
was provided by HOAc-mediated domino reaction of pinacoles with typical
dienophiles, such as 3-methyleneoxindolines and 2-arylideneindane-1,3-diones,
in ionic liquid [Bmim]Br. This domino reaction involved the in situ
generation of 1,3-dienes from acid-mediated dehydration of various
pinacoles and the sequential Diels–Alder reaction.

document-id-old-9ao8b00464document-id-new-14ao-2018-004648ccc-price
==== Body
Introduction
Spiro[cyclohexane-1,3′-indoline]
is one of the most privileged
motifs, which is not only featured in many naturally occurring alkaloids
but also exists in various synthetic pharmaceutical compounds, displaying
a broad spectrum biological activity, such as antimicrobial, anticancer,
and anti-inflammatory activity.1 For example,
gelsemine is an effective agent for treatment of both neuropathic
pain and sleep disturbance in partial sciatic nerve ligation mice.
Satavaptan shows a good effect on maintaining normal sodium level.
The NITD 609 shows pharmacokinetic properties in the treatment of
a rodent malaria model (Figure 1).2 Therefore, the development
of efficient methodology for the construction of spiro[cyclohexane-1,3′-indoline]
has attracted continual interest.3,4 In the past
years, many elegant works have been developed for the synthesis of
diverse spiro[cyclohexane-1,3′-indolines].5 Among various strategies for the construction of spiro[cyclohexane-1,3′-indoline],
the Diels–Alder reaction between various dienes and 3-methyleneindolinones
is the most effective method on the basis of the high diastereoselectivity
and enantioselectivity of the concerted Diels–Alder reaction.6 For example, Inoue reported the Diels–Alder reaction for the synthesis of spirooxindole
utilizing 1,3-pentadiene and 3-methyleneoxindolines. One of the products,
ethyl 6′-bromo-2-methyl-2′-oxospiro[cyclohexane-1,3′-indolin]-3-ene-6-carboxylate,
is the key intermediate in the total synthesis of neosurugatoxin.7

Figure 1 Some biologically active spiro[cyclohexane-1,3′-indolines].

The 2-vinylindole or 3-vinylindole
constantly acts as diene in
the [4 + 2] cycloaddition reaction for the construction of spiro[cyclohexane-1,3′-oxindolines].8 Melchiorre9 and Chen10 described asymmetric Diels–Alder reaction
using methyleneoxindole with in situ generated dienes such as heterocyclic ortho-quinodimethanes and 2,4-dienals to afford spirooxindoles.
Joergensen reported enantioselective Diels–Alder reaction of
trienamines with 3-methyleneoxindoles, yielding functionalized spiro[cyclohexane-1,3′-oxindole]
derivatives.11 Gong also developed bifunctional
organocatalytic asymmetric [4 + 2] cycloaddition of Nazarov reagents,
and methyleneindolinones afforded spirooxindoline derivatives in excellent
yield with excellent diastereo- and enantioselectivity.12 Recently, we successfully developed a TfOH-catalyzed
one-pot domino reaction of indoles, acetophenones, and 3-methyleneoxindolines
for the synthesis of tetrahydrospiro[carbazole-1,3′-indolines],
in which the in situ generated reactive 3-alkenylindole and its sequential
Diels–Alder reaction were the key steps (Scheme 1).13 The reactive
1,3-diene could be prepared by the dehydration of pinacoles under
controlled reaction conditions.14 More
importantly, several sustainable selective dehydration of pinacol
derivatives to branched 1,3-dienes could be carried out in a solid acid/ionic liquid catalyst system,
such as Amberlyst-15/[Emim]Cl and tetrabutylphosphonium bromide.15 We envisioned that spiro[cyclohexane-1,3′-indoline]
framework could be formed via a Diels–Alder reaction between
3-methyleneoxindolines and the in situ generated diene from butane-2,3-dioles
under suitable conditions. To show the synthetic values of this efficient
one-pot domino reaction, herein, we wish to reveal an efficient and
diastereoselective synthetic protocol for the construction of spiro[cyclohexane-1,3′-indolin]-3-en-2′-ones
and spiro[cyclohexane-1,2′-inden]-3-ene-1′,3′-diones
by HOAc-mediated domino reaction of pinacoles with typical dienophiles
such as 3-methyleneoxindolines and 2-arylideneindane-1,3-diones in
ionic liquid [Bmim]Br.

Scheme 1 Synthetic Strategy of Generation of Dienes
and the Diels–Alder
Reaction
Results and Discussion
Initially, the reaction conditions were examined using equivalent
pinacol and 3-methyleneoxindoline 1-benzyl-3-[2-oxo-2-(p-tolyl)ethylidene]indolin-2-one as substrates in ionic liquid [Bmim]Br.
No reaction was observed when heating the two substrates in the [Bmim]Br
at about 120 °C.15 When formic acid
was added as catalyst, the expected spirooxindole 1a was
obtained in 41% yield and the starting material 1-benzyl-3-[2-oxo-2-(p-tolyl)ethylidene]indolin-2-one was also recovered in about
40% yield. After adjusting the ratio of pinacol to 1-benzyl-3-[2-oxo-2-(p-tolyl)ethylidene]indolin-2-one to 2:1, the product 1a was still obtained in moderate yield and a reduced 1-benzyl-3-[2-oxo-2-(p-tolyl)ethyl]indolin-2-one was separated from the system
in 34% yield. It is obvious that formic acid reacted as a reducing
reagent to cause the partial reduction of 1-benzyl-3-[2-oxo-2-(p-tolyl)ethylidene]indolin-2-one. When the reaction was
performed in [Bmim]Br in presence of acetic acid (25%), the target
spiro[cyclohexane-1,3′-indolin]-3-en-2′-ones 1a was successfully obtained in satisfactory yield (86%) and the reduced
product was not observed. Reducing the amount of acetic acid and carrying
out the reaction at lower temperature would greatly reduce the yields
of 1a. Thus, optimized reaction conditions were successfully
obtained.

Under the optimized conditions, a variety of substrates
was then
examined (Table 1).
The reaction between pinacol and various substituted 3-phenacylideneoxindolines
proceeded smoothly to give spiro[cyclohexane-1,3′-indolin]-3-en-2′-ones 1a–f in 72–86% yields. The pinacol
derivatives, such as 2,3-diphenylbutane-2,3-diol and 2,3-di(p-tolyl)butane-2,3-diol, were also employed in the reaction
to give the expected functionalized spiro[cyclohexane-1,3′-indolin]-3-en-2′-ones 1g–m in 73–85% yields. The two
phenyl groups in the substrates did not cause an unfavorable effect
on the domino Diels–Alder reaction. It can be seen that the
substituents on 3-phenacylideneoxindolines have a little effect on
yields of products. The structures of the obtained spiro compound
products 1a–m were fully characterized
by IR, high-resolution mass spectrometry (HRMS), 1H NMR,
and 13C NMR spectra. Because there are two adjacent chiral
carbon atoms in the newly formed cyclohexenyl ring, the cis/trans-diastereoisomers
could be formed in the reactions. 1H NMR spectra showed
that only one set of characterized signals was observed for the typical
groups in the molecule. The single-crystal structure of 1a (Figure 2), 1g, and 1h (Figures S1 and S2) was successfully determined by single X-ray diffraction.
The three compounds have the same relative configuration. From Figure 1, it can be seen
that the phenacyl group and the phenyl group of oxindoline moiety
stand at cis-position. It has been known that the phenacyl group usually
exists at cis-position to the phenyl group of the oxindoline moiety
in 3-phenacylideneoxindoline.16 Thus, the
cis-configuration was retained in the domino reaction, which also
indicated that the reaction proceeded according to the concerted Diels–Alder
reaction mechanism.

Figure 2 Crystal structure of compound 1a.

Table 1 Synthesis of Spiro[cyclohexane-1,3′-indolin]-3-en-2′-ones 1a–ma,b
a Reaction conditions:
pinacol (1.0
mmol), 3-phenacylideneoxindole (0.5 mmol), [Bmim]Br (2.0 mL), HOAc
(0.5 mL), 15 h.

b Isolated
yield.

For developing the
scope of the reaction, another common 3-methyleneoxindolines, ethyl (E)-2-(2-oxoindolin-3-ylidene)acetates
were employed in the reaction under the same conditions. The results
are summarized in Table 2. The expected functionalized spiro[cyclohexane-1,3′-indolin]-3-en-2′-ones 2a–g were successfully obtained in 69–83%
yields. It should be pointed out that the oxindolines without N-substituent
reacted well to give spiro compounds 2f and 2g in good yields. The structures of obtained spiro [cyclohexane-1,3′-indolin]-3-en-2′-ones 2a–g were established on various spectroscopies.
Additionally, the single-crystal structure of compound 2b (Figure 3) was confirmed
by X-ray diffraction. The single-crystal structure of compound 2b clearly demonstrated that the ethoxycarbonyl group and
the phenyl group of oxindoline moiety exist in cis-position. Thus,
the spiro compound 2b has the same relative configuration
as that of above-mentioned compounds 1a, 1g, and 1h. This result also indicated the acid-mediated
domino reaction has a high diastereoselectivity.

Figure 3 Crystal structure of
compound 2b.

Table 2 Synthesis of Spiro[cyclohexane-1,3′-indolin]-3-en-2′-ones 2a–ga,b
a Reaction conditions:
pinacol (1.0
mmol), 3-methylideneoxindole (0.5 mmol), [Bmim]Br (2 mL), HOAc (0.5
mL), 15 h.

b Isolated yield.

For exploring the synthetic
value of the reaction, 2-arylideneindane-1,3-diones
were also employed in the reaction. The acid-mediated domino reaction
of 2,3-diarylpinacols with 3-phenacylideneoxindoles in [Bmim]Br afforded
the expected spiro[cyclohexane-1,2′-inden]-3-ene-1′,3′-diones 3a–h in moderate to good yield. The results
are summarized in Table 3. The relative lower yields were due to partial decomposition of
2-arylideneindane-1,3-diones in acidic medium at high temperature.
The obtained products 3a–h were also
characterized by the IR, HRMS, 1H, and 13C NMR
spectroscopies. To confirm the structure of product, the single-crystal
structure of spiro compound 3d was determined by X-ray
diffraction analysis (Figure 4).

Figure 4 Crystal structure of compound 3d.

Table 3 Synthesis of Spiro[cyclohexane-1,2′-inden]-3-ene-1′,3′-diones 3a–ha,b
a Reaction conditions:
pinacol (1.0
mmol), 2-arylidene-1,3-indanedione (0.5 mmol), [Bmim]Br (2 mL), HOAc
(0.5 mL), 15 h.

b Isolated
yield.

Conclusions
In
summary, we have studied in situ generation of dienes from acid-mediated
dehydration of various pinacoles in ionic liquid [Bmim]Br and a sequential
Diels–Alder reaction with typical dienophiles such as 3-methyleneoxindolines
and 2-arylidene-1,3-indanediones. This domino reaction not only provided
the efficient synthetic methodology for 1,3-dienes but also developed
a novel synthetic protocol for the construction of spiro[cyclohexane-1,3′-indolin]-3-en-2′-ones
and spiro[cyclohexane-1,2′-inden]-3-ene-1′,3′-diones.
The advantages of this domino reaction included readily available
starting materials, simple reaction conditions, broad scope of substrates,
satisfactory yields, and high diastereoselectivity, which will enable
it to find potential applications in synthetic and medicinal chemistry.

Experimental
Section
General Procedure for the Domino Diels–Alder Reaction
To a solution of ionic liquid ([Bmim]Br) (2.0 mL) were added pinacol
(1.0 mmol), 3-phenacylideneoxindole or 2-arylidene-1,3-indanedione
(0.5 mmol), and acetic acid (0.5 mL) in a 10 mL tube; the mixture
were heat at 120 °C for 15 h. After cooling to room temperature,
the mixture was poured into water (50.0 mL). The organic layer was
extracted with ethyl acetate and dried with anhydrous Na2SO4. After removing the solvent at reduced pressure by
rotator evaporation, the residue was subjected to column chromatography
with a mixture of light petroleum and ethyl acetate (v/v = 5:1) as
eluent to give the pure products for analysis.

1′-Benzyl-3,4-dimethyl-6-(4-methylbenzoyl)spiro[cyclohexane-1,3′-indolin]-3-en-2′-one
(1a)
White solid, 86%, 0.187 g, mp 118–120
°C; 1H NMR (400 MHz, CDCl3) δ: 7.78–7.76
(m, 2H, ArH), 7.29–7.19 (m, 7H, ArH), 7.12 (d, J = 8.4 Hz, 1H, ArH), 6.98 (s, 1H, ArH), 6.93 (d, J = 8.4 Hz, 1H, ArH), 4.90 (d, J = 16.0 Hz, 1H, CH),
4.82 (d, J = 16.0 Hz, 1H, CH), 4.31–4.26 (m,
1H, CH), 2.89 (d, J = 16.8 Hz, 1H, CH), 2.57–2.49
(m, 2H, CH), 2.39 (s, 3H, CH3), 1.85–1.75 (m, 4H,
CH, CH3), 1.70 (s, 3H, CH3); 13C
NMR (100 MHz, CDCl3) δ: 199.6, 179.2, 143.9, 141.2,
135.5, 134.9, 129.2, 128.7, 128.6, 127.6, 127.4, 127.1, 127.0, 124.9,
124.1, 124.0, 109.8, 48.8, 47.5, 43.9, 41.5, 33.5, 21.6, 19.1, 18.6;
IR (KBr) υ: 3029, 2931, 2841, 1695, 1608, 1484, 1435, 1283,
1173, 1075, 1024, 815, 743 cm–1; MS (m/z): HRMS (ESI) calcd for C30H30NO2 ([M + H]+): 436.2277. Found: 436.2293.

6-Benzoyl-1′-benzyl-5′-chloro-3,4-dimethylspiro[cyclohexane-1,3′-indolin]-3-en-2′-one
(1b)
White solid, 80%, 0.182 g, mp 112–114
°C; 1H NMR (400 MHz, CDCl3) δ: 7.87–7.85
(m, 2H, ArH), 7.55–7.52 (m, 1H, ArH), 7.44–7.41 (m,
2H, ArH), 7.30–7.25 (m, 2H, ArH), 7.22–7.20 (m, 3H,
ArH), 7.13 (d, J = 8.0 Hz, 1H, ArH), 6.99 (s, 1H,
ArH), 6.64 (d, J = 7.6 Hz, 1H, ArH), 4.90 (d, J = 15.6 Hz, 1H, CH), 4.82 (d, J = 16.0
Hz, 1H, CH), 4.33–4.29 (m, 1H, CH), 2.90 (d, J = 16.8 Hz, 1H, CH), 2.57–2.44 (m, 2H, CH), 1.86–1.80
(m, 4H, CH, CH3), 1.70 (s, 3H, CH3); 13C NMR (100 MHz, CDCl3) δ: 200.1, 179.2, 141.2, 136.2,
135.5, 134.8, 133.3, 132.9, 128.9, 128.7, 128.7, 128.4, 128.4, 128.3,
127.6, 127.4, 127.2, 127.0, 126.8, 124.9, 124.1, 123.9, 109.9, 48.7,
47.8, 43.9, 41.6, 33.3, 19.1, 18.6; IR (KBr) υ: 1700, 1604,
1485, 1433, 1288, 1173, 1075, 1027, 814, 745 cm–1; MS (m/z): HRMS (ESI) calcd for
C29H26ClNNaO2 ([M + Na]+): 478.1550. Found: 478.1545.

1′-Benzyl-5′-chloro-3,4-dimethyl-6-(4-methylbenzoyl)spiro[cyclohexane-1,3′-indolin]-3-en-2′-one
(1c)
White solid, 79%, 0.184 g, mp 132–134
°C; 1H NMR (400 MHz, CDCl3) δ: 7.78–7.76
(m, 2H, ArH), 7.29–7.19 (m, 7H, ArH), 7.12 (dd, J1 = 8.4 Hz, J1 = 2.0 Hz, 1H,
ArH), 6.99–6.98 (m, 1H, ArH), 6.63 (d, J =
8.0 Hz, 1H, ArH), 4.90 (d, J = 16.0 Hz, 1H, CH),
4.82 (d, J = 15.6 Hz, 1H, CH), 4.29 (dd, J1 = 11.6 Hz, J1 =
6.8 Hz, 1H, CH), 2.89 (d, J = 16.8 Hz, 1H, CH), 2.57–2.49
(m, 2H, CH), 2.39 (s, 3H, CH3), 1.86–1.80 (m, 4H,
CH, CH3), 1.70 (s, 3H, CH3); 13C
NMR (150 MHz, CDCl3) δ: 199.7, 179.3, 144.0, 141.2,
135.5, 134.9, 133.6, 129.3, 128.7, 127.6, 127.4, 127.2, 127.0, 125.0,
124.1, 124.0, 109.8, 48.8, 47.6, 43.9, 41.5, 33.5, 21.6, 19.1, 18.7;
IR (KBr) υ: 1708, 1698, 1608, 1482, 1435, 1285, 1171, 1075,
1023, 821, 743, 728 cm–1; MS (m/z): HRMS (ESI) calcd for C30H29ClNO2 ([M + H]+): 470.1887. Found: 470.1882.

1′-Butyl-5′-chloro-6-(4-methoxybenzoyl)-3,4-dimethylspiro[cyclohexane-1,3′-indolin]-3-en-2′-one
(1d)
White solid, 72%, 0.162 g, mp 109–111
°C; 1H NMR (400 MHz, CDCl3) δ: 7.84–7.82
(m, 2H, ArH), 7.26–7.23 (m, 1H, ArH), 7.01–7.00 (m,
1H, ArH), 6.89–6.87 (m, 2H, ArH), 6.80 (d, J = 8.4 Hz, 1H, ArH), 4.19 (dd, J1 = 12.0
Hz, J1 = 6.4 Hz, 1H, CH), 3.84 (s, 3H,
OCH3), 3.70–3.63 (m, 1H, CH), 3.57–3.50 (m,
1H, CH), 2.82 (d, J = 16.4 Hz, 1H, CH), 2.55–2.44
(m, 2H, CH), 1.79–1.74 (m, 5H, CH, CH3), 1.69 (s,
3H, CH3), 1.55–1.43 (m, 2H, CH), 1.29–1.27
(m, 1H, CH), 2.55–2.44 (t, J = 7.2 Hz, 3H,
CH3); 13C NMR (150 MHz, CDCl3) δ:
198.3, 178.9, 163.5, 141.6, 135.1, 130.9, 129.2, 127.3, 127.2, 124.9,
124.2, 124.0, 113.6, 108.8, 55.4, 48.8, 47.0, 41.1, 39.9, 33.4, 29.2,
20.0, 19.0, 18.6, 13.7; IR (KBr) υ: 3021, 2930, 2844, 1705,
1605, 1487, 1441, 1286, 1178, 1105, 1029, 815, 743, 702 cm–1; MS (m/z): HRMS (ESI) calcd for
C27H31ClNO3 ([M + H]+):
452.1992. Found: 452.1981.

1′-Benzyl-5′-fluoro-3,4-dimethyl-6-(4-methylbenzoyl)spiro[cyclohexane-1,3′-indolin]-3-en-2′-one
(1e)
White solid, 78%, 0.177 g, mp 138–140
°C; 1H NMR (400 MHz, CDCl3) δ: 7.79–7.77
(m, 2H, ArH), 7.28–7.26 (m, 1H, ArH), 7.24–7.19 (m,
6H, ArH), 6.87–6.79 (m, 2H, ArH), 6.62 (dd, J1 = 8.4 Hz, J1 = 4.4 Hz, 1H,
ArH), 4.90 (d, J = 15.6 Hz, 1H, CH), 4.81 (d, J = 16.0 Hz, 1H, CH), 4.31 (dd, J1 = 13.2 Hz, J1 = 8.8 Hz, 1H, CH), 2.91
(d, J = 16.4 Hz, 1H, CH), 2.55–2.44 (m, 2H,
CH), 2.38 (s, 3H, CH3), 1.85–1.79 (m, 4H, CH, CH3), 1.69 (s, 3H, CH3); 13C NMR (150 MHz,
CDCl3) δ: 199.8, 179.5, 159.1 (d, J = 237.0 Hz), 144.0, 138.5, 135.7, 134.8 (d, J =
8.3 Hz), 133.7, 129.3, 128.8, 128.7, 127.4, 127.1, 125.0, 124.1, 113.4
(d, J = 23.1 Hz), 112.0 (d, J =
25.4 Hz), 109.3 (d, J = 8.1 Hz), 49.0, 47.4, 44.0,
41.5, 33.5, 21.6, 19.1, 18.6; IR (KBr) υ: 3034, 2933, 2842,
1711, 1602, 1485, 1433, 1287, 1178, 1095, 1027, 815, 740 cm–1; MS (m/z): HRMS (ESI) calcd for
C30H29FNO2 ([M + H]+):
454.2182. Found: 454.2179.

1′-Benzyl-5′-methyl-3,4-dimethyl-6-(4-methoxybenzoyl)spiro[cyclohexane-1,3′-indolin]-3-en-2′-one
(1f)
White solid, 84%, 0.195 g, mp 124–126
°C; 1H NMR (400 MHz, CDCl3) δ: 7.90–7.88
(m, 2H, ArH), 7.25–7.17 (m, 5H, ArH), 6.95 (d, J = 7.2 Hz, 1H, ArH), 6.90–6.83 (m, 3H, ArH), 6.59 (d, J = 7.6 Hz, 1H, ArH), 4.88 (d, J = 16.0
Hz, 1H, CH), 4.75 (d, J = 16.0 Hz, 1H, CH), 4.26
(dd, J1 = 11.2 Hz, J1 = 8.8 Hz, 1H, CH), 3.84 (s, 3H, OCH3), 2.89 (d, J = 16.4 Hz, 1H, CH), 2.64–2.57 (m, 1H, CH), 2.47–2.43
(m, 1H, CH), 2.28 (s, 3H, CH3), 1.81 (s, 3H, CH3), 1.70 (s, 3H, CH3); 13C NMR (100 MHz, CDCl3) δ: 198.4, 179.5, 163.4, 140.1, 136.0, 133.1, 131.5,
130.9, 129.4, 128.5, 127.6, 127.1, 127.0, 124.8, 124.6, 124.1, 113.6,
108.6, 55.4, 48.9, 46.8, 43.8, 41.5, 33.6, 21.4, 19.0, 18.6; IR (KBr)
υ: 3030, 2931, 2843, 1709, 1692, 1608, 1487, 1438, 1286, 1174,
1075, 1024, 817, 743 cm–1; MS (m/z): HRMS (ESI) calcd for C31H32NO3 ([M + H]+): 466.2382. Found: 466.2374.

1′-Benzyl-3,4-diphenyl-6-(4-methylbenzoyl)spiro[cyclohexane-1,3′-indolin]-3-en-2′-one
(1g)
White solid, 81%, 0.226 g, mp 201–203
°C; 1H NMR (400 MHz, CDCl3) δ: 7.86–7.84
(m, 2H, ArH), 7.47 (d, J = 7.6 Hz, 1H, ArH), 7.25–7.19
(m, 8H, ArH), 7.18–7.14 (m, 2H, ArH), 7.12–7.08 (m,
6H, ArH), 7.07–7.05 (m, 1H, ArH), 6.98–6.96 (m, 2H,
ArH), 6.78 (d, J = 7.6 Hz, 1H, ArH), 4.92 (d, J = 15.6 Hz, 1H, CH), 4.85 (d, J = 16.0
Hz, 1H, CH), 4.63–4.59 (m, 1H, CH), 3.44–3.38 (m, 1H,
CH), 3.10–3.08 (m, 2H, CH), 2.42 (d, J = 17.6
Hz, 1H, CH), 2.39 (s, 3H, CH3); 13C NMR (100
MHz, CDCl3) δ: 199.2, 179.1, 143.9, 142.7, 141.9,
141.5, 135.8, 133.9, 133.7, 133.2, 132.7, 129.2, 128.8, 128.8, 128.6,
128.0, 127.9, 127.6, 127.3, 127.1, 126.6, 126.4, 123.6, 122.6, 109.3,
48.4, 47.2, 43.9, 42.2, 33.6, 21.6; IR (KBr) υ: 3035, 2929,
1701, 1602, 1483, 1428, 1350, 1291, 1023, 955, 870, 742, 700 cm–1; MS (m/z): HRMS
(ESI) calcd for C40H34NO2 ([M + H]+): 560.2590. Found: 560.2611.

1′-Benzyl-5′-chloro-3,4-diphenyl-6-(4-methylbenzoyl)spiro[cyclohexane-1,3′-indolin]-3-en-2′-one
(1h)
White solid, 79%, 0.234 g, mp 208–210
°C; 1H NMR (400 MHz, CDCl3) δ: 7.85–7.83
(m, 2H, ArH), 7.43 (d, J = 1.6 Hz, 1H, ArH), 7.29–7.24
(m, 5H, ArH), 7.22–7.19 (m, 3H, ArH), 7.17–7.13 (m,
2H, ArH), 7.12–7.08 (m, 6H, ArH), 6.98–6.96 (m, 2H,
ArH), 6.69 (d, J = 8.0 Hz, 1H, ArH), 4.93 (d, J = 16.0 Hz, 1H, CH), 4.86 (d, J = 16.0
Hz, 1H, CH), 4.63–4.58 (m, 1H, CH), 3.40 (d, J = 17.6 Hz, 1H, CH), 3.16–3.10 (m, 1H, CH), 3.05–2.97
(m, 1H, CH), 2.43–2.39 (m, 4H, CH, CH3); 13C NMR (100 MHz, CDCl3) δ: 199.1, 178.8, 144.2, 141.6,
141.3, 141.2, 135.4, 134.5, 133.9, 133.6, 133.0, 129.3, 128.7, 128.7,
128.7, 128.7, 128.1, 128.0, 127.9, 127.5, 127.4, 127.0, 126.7, 126.6,
124.1, 110.1, 48.4, 47.5, 44.0, 42.1, 33.6, 21.6; IR (KBr) υ:
3051, 2925, 2838, 1709, 1680, 1602, 1482, 1434, 1370, 1338, 1284,
1222, 1186, 1110, 1073, 1023, 960, 912, 871, 810, 742 cm–1; MS (m/z): HRMS (ESI) calcd for
C40H33ClNO2 ([M + H]+):
594.2200. Found: 594.2210.

6-Benzoyl-1′-benzyl-5′-chloro-3,4-diphenylspiro[cyclohexane-1,3′-indolin]-3-en-2′-one
(1i)
White solid, 85%, 0.246 g, mp 208–209
°C; 1H NMR (400 MHz, CDCl3) δ: 7.94–7.92
(m, 2H, ArH), 7.57–7.53 (m, 1H, ArH), 7.47–7.43 (m,
3H, ArH), 7.29–7.25 (m, 2H, ArH), 7.24–7.23 (m, 2H,
ArH), 7.21–7.15 (m, 4H, ArH), 7.17–7.13 (m, 2H, ArH),
7.12–7.08 (m, 6H, ArH), 6.98–6.96 (m, 2H, ArH), 6.69
(d, J = 8.0 Hz, 1H, ArH), 4.93 (d, J = 16.0 Hz, 1H, CH), 4.86 (d, J = 16.0 Hz, 1H, CH),
4.65–4.61 (m, 1H, CH), 3.41 (d, J = 17.2 Hz,
1H, CH), 3.17–3.11 (m, 1H, CH), 3.06–2.97 (m, 1H, CH),
2.41 (d, J = 17.2 Hz, 1H, CH); 13C NMR
(100 MHz, CDCl3) δ: 199.6, 178.7, 141.6, 141.3, 141.2,
136.1, 135.3, 134.4, 133.8, 133.2, 133.0, 128.7, 128.7, 128.7, 128.6,
128.5, 128.1, 127.9, 127.9, 127.5, 127.0, 126.7, 126.6, 124.1, 110.1,
48.4, 47.6, 44.0, 42.1, 33.4; IR (KBr) υ: 3032, 2938, 1693,
1605, 1484, 1431, 1345, 1283, 1175, 1074, 1024, 958, 910, 872, 811,
742 cm–1; MS (m/z): HRMS (ESI) calcd for C39H31ClNO2 ([M + H]+): 580.2043. Found: 580.2062.

1′-Benzyl-5′-chloro-3,4-diphenyl-6-(4-chlorobenzoyl)spiro[cyclohexane-1,3′-indolin]-3-en-2′-one
(1j)
White solid, 77%, 0.236 g, mp 199–200
°C; 1H NMR (400 MHz, CDCl3) δ: 7.88–7.86
(m, 2H, ArH), 7.43–7.41 (m, 3H, ArH), 7.29–7.27 (m,
1H, ArH), 7.25–7.23 (m, 2H, ArH), 7.21–7.18 (m, 4H,
ArH), 7.16–7.06 (m, 7H, ArH), 6.98–6.96 (m, 2H, ArH),
6.70 (d, J = 8.0 Hz, 1H, ArH), 4.92 (d, J = 16.0 Hz, 1H, CH), 4.84 (d, J = 15.6 Hz, 1H, CH),
4.59–4.55 (m, 1H, CH), 3.41–3.36 (m, 1H, CH), 3.12–2.97
(m, 2H, CH), 2.42 (d, J = 17.2 Hz, 1H, CH); 13C NMR (100 MHz, CDCl3) δ: 198.4, 178.6,
141.5, 141.3, 141.1, 139.8, 135.2, 134.4, 134.1, 133.6, 133.0, 130.0,
129.0, 128.7, 128.6, 128.1, 128.0, 128.0, 127.6, 127.5, 127.0, 126.8,
126.6, 124.2, 110.1, 48.5, 47.4, 44.1, 41.9, 33.3; IR (KBr) υ:
3045, 2933, 1697, 1604, 1489, 1434, 1371, 1284, 1175, 1089, 1026,
949, 815, 741, 695 cm–1; MS (m/z): HRMS (ESI) calcd for C39H30Cl2NO2 ([M + H]+): 614.1654. Found: 614.1664.

1′-Benzyl-5′-methyl-3,4-diphenyl-6-(4-chlorobenzoyl)spiro[cyclohexane-1,3′-indolin]-3-en-2′-one
(1k)
White solid, 73%, 0.216 g, mp 197–199
°C; 1H NMR (400 MHz, CDCl3) δ: 7.89–7.87
(m, 2H, ArH), 7.41–7.39 (m, 2H, ArH), 7.31 (s, 1H, ArH), 7.25–7.16
(m, 7H, ArH), 7.13–7.02 (m, 7H, ArH), 6.98–6.96 (m,
2H, ArH), 6.68–6.66 (m, 1H, ArH), 4.89 (d, J = 16.0 Hz, 1H, CH), 4.80 (d, J = 16.0 Hz, 1H, CH),
4.59–4.54 (m, 1H, CH), 3.40 (d, J = 17.2 Hz,
1H, CH), 3.15–3.00 (m, 2H, CH), 2.43 (d, J = 17.6 Hz, 1H, CH), 2.34 (s, 3H, CH3); 13C
NMR (100 MHz, CDCl3) δ: 198.5, 178.8, 141.8, 141.5,
140.2, 139.6, 135.8, 134.7, 133.5, 133.3, 132.4, 131.9, 130.1, 128.9,
128.8, 128.7, 128.6, 128.1, 128.1, 127.9, 127.3, 127.0, 126.7, 126.5,
124.7, 109.0, 48.5, 47.1, 43.9, 42.1, 33.3, 21.5; IR (KBr) υ:
3027, 2984, 2919, 1722, 1608, 1483, 1428, 1352, 1276, 1209, 1110,
1027, 944, 869, 817, 744, 705 cm–1; MS (m/z): HRMS (ESI) calcd for C40H33ClNO2 ([M + H]+): 594.2200. Found:
594.2218.

1′-Butyl-5′-chloro-3,4-diphenyl-6-(4-methoxybenzoyl)spiro[cyclohexane-1,3′-indolin]-3-en-2′-one
(1l)
White solid, 80%, 0.230 g, mp 207–209
°C; 1H NMR (400 MHz, CDCl3) δ: 7.92–7.90
(m, 2H, ArH), 7.43 (d, J = 2.0 Hz, 1H, ArH), 7.30
(dd, J1 = 8.4 Hz, J2 = 2.0 Hz, 1H, ArH), 7.19–7.16 (m, 2H, ArH), 7.14–7.07
(m, 6H, ArH), 6.98–6.96 (m, 2H, ArH), 6.91–6.89 (m,
2H, ArH), 6.85 (d, J = 8.4 Hz, 1H, ArH), 4.53–4.48
(m, 1H, CH), 3.85 (s, 3H, OCH3), 3.73–3.66 (m, 1H,
CH), 3.61–3.54 (m, 1H, CH), 3.35–3.30 (m, 1H, CH), 3.06–3.04
(m, 2H, CH), 2.34 (d, J = 17.6 Hz, 1H, CH), 1.57–1.46
(m, 2H, CH), 1.29–1.23 (m, 2H, CH), 0.86 (t, J = 7.2 Hz, 3H, CH3); 13C NMR (100 MHz, CDCl3) δ: 197.7, 178.4, 163.6, 141.7, 141.6, 141.3, 134.7,
133.9, 132.9, 130.9, 129.2, 128.7, 128.7, 128.1, 127.9, 127.5, 127.4,
126.6, 126.5, 124.2, 113.7, 109.1, 55.4, 48.4, 46.9, 41.6, 40.0, 33.5,
29.2, 20.0, 13.6; IR (KBr) υ: 3069, 2959, 2926, 1706, 1666,
1600, 1484, 1428, 1356, 1314, 1262, 1218, 1175, 1115, 1024, 951, 916,
849, 817, 743, 701 cm–1; MS (m/z): HRMS (ESI) calcd for C37H35ClNO3 ([M + H]+): 576.2305. Found: 576.2324.

1′-Benzyl-5′-fluoro-3,4-(bis-4-methylphenyl)-6-(4-methylbenzoyl)spiro[cyclohexane-1,3′-indolin]-3-en-2′-one
(1m)
White solid, 83%, 0.251 g, mp 170–172
°C; 1H NMR (400 MHz, CDCl3) δ: 7.85–7.83
(m, 2H, ArH), 7.28–7.26 (m, 1H, ArH), 7.25–7.24 (m,
2H, ArH), 7.23–7.16 (m, 5H, ArH), 7.00–6.96 (m, 4H,
ArH), 6.94–6.89 (m, 3H, ArH), 6.87–6.85 (m, 2H, ArH),
6.66 (dd, J1 = 8.4 Hz, J2 = 4.4 Hz, 1H, ArH), 4.91 (d, J = 16.0
Hz, 1H, CH), 4.85 (d, J = 16.0 Hz, 1H, CH), 4.61–4.57
(m, 1H, CH), 3.38 (d, J = 17.2 Hz, 1H, CH), 3.12–3.06
(m, 1H, CH), 3.02–2.98 (m, 1H, CH), 2.39–2.35 (m, 4H,
CH, CH3), 2.25 (s, 3H, CH3), 2.23 (s, 3H, CH3); 13C NMR (100 MHz, CDCl3) δ:
199.3, 179.0, 159.2 (d, J = 238.0 Hz), 144.1, 138.9,
138.7, 138.6, 138.4, 136.3, 136.1, 135.5, 134.5 (d, J = 8.4 Hz), 133.7, 133.1, 132.3, 129.3, 128.8, 128.7, 128.7, 128.6,
128.6, 127.4, 127.0, 113.6 (d, J = 23.2 Hz), 112.0
(d, J = 25.5 Hz), 109.5 (d, J =
8.3 Hz), 48.7, 48.7, 47.4, 44.0, 42.2, 33.6, 21.6, 21.0; IR (KBr)
υ: 3027, 2960, 2926, 2872, 1708, 1608, 1495, 1437, 1360, 1293,
1195, 1107, 1035, 853, 816, 745 cm–1; MS (m/z): HRMS (ESI) calcd for C42H37FNO2 ([M + H]+): 606.2808. Found:
606.2834.

Ethyl 1′-benzyl-3,4-(bis-4-methylphenyl)-2′-oxospiro[cyclohexane-1,3′-indolin]-3-ene-6-carboxylate
(2a)
White solid, 69%, 0.186 g, mp 151–153
°C; 1H NMR (400 MHz, CDCl3) δ: 7.30
(d, J = 7.2 Hz, 1H, ArH), 7.27–7.25 (m, 2H,
ArH), 7.22–7.18 (m, 2H, ArH), 7.15–7.11 (m, 1H, ArH),
7.09–7.05 (m, 1H, ArH), 6.96–6.94 (m, 2H, ArH), 6.92–6.89
(m, 3H, ArH), 6.79–6.77 (m, 2H, ArH), 6.73–6.71 (m,
2H, ArH), 6.68 (d, J = 7.6 Hz, 1H, ArH), 5.01 (d, J = 16.0 Hz, 1H, CH), 4.77 (d, J = 15.6
Hz, 1H, ArH), 3.86–3.75 (m, 2H, CH), 3.56 (dd, J1 = 11.2 Hz, J2 = 6.8 Hz,
1H, CH), 3.17 (d, J = 16.8 Hz, 1H, CH), 3.13–2.94
(m, 2H, CH), 2.27–2.23 (m, 1H, CH), 2.16 (s, 3H, CH3), 2.09 (s, 3H, CH3), 0.87 (t, J = 7.2
Hz, 3H, CH3); 13C NMR (100 MHz, CDCl3) δ: 179.6, 171.6, 143.0, 139.1, 138.8, 136.1, 136.1, 135.9,
132.8, 132.1, 131.8, 128.8, 128.7, 128.6, 127.9, 127.5, 127.3, 123.8,
122.5, 109.1, 60.6, 48.0, 44.6, 44.1, 42.2, 32.0, 21.1, 21.1, 13.9;
IR (KBr) υ: 3024, 2981, 2919, 1720, 1610, 1483, 1428, 1352,
1273, 1207, 1107, 1029, 944, 868, 818, 744 cm–1;
MS (m/z): HRMS (ESI) calcd for C37H36NO3 ([M + H]+): 546.2695.
Found: 542.2692.

Ethyl 1′-butyl-5′-fluoro-3,4-(bis-4-methylphenyl)-2′-oxospiro[cyclohexane-1,3′-indolin]-3-ene-6-carboxylate
(2b)
White solid, 82%, 0.215 g, mp 163–165
°C; 1H NMR (400 MHz, CDCl3) δ: 7.12
(dd, J1 = 8.4 Hz, J2 = 2.4 Hz, 1H, ArH), 7.04–7.01 (m, 4H, ArH), 6.99 (dd, J1 = 8.8 Hz, J2 =
2.4 Hz, 1H, ArH), 6.90–6.88 (m, 2H, ArH), 6.83–6.79
(m, 3H, ArH), 3.98–3.89 (m, 2H, CH), 3.83–3.76 (m, 1H,
CH), 3.73–3.64 (m, 1H, CH), 3.58 (d, J1 = 11.6 Hz, J2 = 6.4 Hz, 1H, CH),
3.19–3.13 (m, 2H, CH), 3.02–2.94 (m, 1H, CH), 2.28–2.23
(m, 4H, CH, CH3), 2.21 (s, 3H, CH3), 1.71–1.64
(m, 2H, CH), 1.45–1.36 (m, 2H, CH), 1.05 (t, J = 7.2 Hz, 3H, CH3), 0.96 (t, J = 7.2
Hz, 3H, CH3); 13C NMR (100 MHz, CDCl3) δ: 179.0, 171.4, 160.0, 158.9 (d, J = 238.1
Hz), 139.4 (d, J = 1.7 Hz), 138.8, 138.6, 136.2,
135.9, 133.5 (d, J = 8.1 Hz), 132.7, 131.9, 128.8,
128.6, 128.6, 128.6, 113.9 (d, J = 23.2 Hz), 112.2
(d, J = 25.0 Hz), 108.5 (d, J =
8.1 Hz), 60.6, 48.1, 44.5, 41.7, 40.1, 31.9, 29.3, 21.1, 21.0, 20.1,
13.9, 13.7; IR (KBr) υ: 3024, 2987, 2923, 1707, 1608, 1477,
1433, 1352, 1274, 1213, 1108, 1027, 943, 865, 817, 743, 702 cm–1; MS (m/z): HRMS
(ESI) calcd for C34H37FNO3 ([M +
H]+): 526.2757. Found: 526.2754.

Ethyl 1′-benzyl-5′-chloro-3,4-(bis-4-methylphenyl)-2′-oxospiro[cyclohexane-1,3′-indolin]-3-ene-6-carboxylate
(2c)
White solid, 76%, 0.218 g, mp 154–155
°C; 1H NMR (400 MHz, CDCl3) δ: 7.35–7.34
(m, 1H, ArH), 7.32–7.28 (m, 4H, ArH), 7.27–7.25 (m,
1H, ArH), 7.15 (dd, J1 = 8.4 Hz, J2 = 2.0 Hz, 1H, ArH), 7.05–7.01 (m, 4H,
ArH), 6.92–6.90 (m, 2H, ArH), 6.83–6.81 (m, 2H, ArH),
6.67 (d, J = 8.4 Hz, 1H, ArH), 5.08 (d, J = 15.6 Hz, 1H, CH), 4.85 (d, J = 15.6 Hz, 1H, CH),
4.02–3.95 (m, 1H, CH), 3.94–3.88 (m, 1H, CH), 3.67–3.63
(m, 1H, CH), 3.62–3.18 (m, 2H, CH), 2.34–2.28 (m, 4H,
CH, CH3), 2.22 (s, 3H, CH3), 1.04 (t, J = 7.2 Hz, 3H, CH3); 13C NMR (100
MHz, CDCl3) δ: 179.2, 171.4, 141.7, 138.7, 138.5,
136.2, 136.0, 135.6, 133.5, 133.0, 131.8, 128.8, 128.7, 128.6, 128.6,
127.7, 127.6, 127.2, 124.3, 109.9, 60.8, 48.1, 44.6, 44.2, 42.0, 32.0,
21.1, 21.0, 13.9; IR (KBr) υ: 3048, 2981, 2919, 2846, 1710,
1609, 1592, 1437, 1356, 1273, 1195, 1113, 1031, 866, 818, 741 cm–1; MS (m/z): HRMS
(ESI) calcd for C37H35ClNO3 ([M +
H]+): 576.2305. Found: 576.2331.

Ethyl 1′-butyl-5′-methyl-3,4-(bis-4-methylphenyl)-2′-oxospiro[cyclohexane-1,3′-indolin]-3-ene-6-carboxylate
(2d)
White solid, 75%, 0.195 g, mp 150–152
°C; 1H NMR (400 MHz, CDCl3) δ: 7.19
(s, 1H, ArH), 7.08 (d, J = 8.0 Hz, 1H, ArH), 7.04–7.00
(m, 4H, ArH), 6.89–6.87 (m, 2H, ArH), 6.81–6.78 (m,
3H, CH), 3.96–3.87 (m, 2H, CH), 3.83–3.76 (m, 1H, CH),
3.71–3.64 (m, 1H, CH), 3.57–3.53 (m, 1H, CH), 3.17–3.00
(m, 3H, CH), 2.31–2.23 (m, 7H, CH, 2CH3), 2.20 (s,
3H, CH3), 1.72–1.64 (m, 2H, CH), 1.45–1.36
(m, 2H, CH), 1.02 (t, J = 7.2 Hz, 3H, CH3), 0.95 (t, J = 7.2 Hz, 3H, CH3); 13C NMR (100 MHz, CDCl3) δ: 179.2, 171.6,
140.9, 139.1, 139.0, 136.0, 135.7, 132.7, 132.2, 132.0, 131.3, 128.7,
128.7, 128.5, 128.0, 124.9, 107.9, 60.4, 47.8, 44.5, 41.9, 40.0, 32.0,
29.4, 21.4, 21.1, 21.0, 20.2, 13.9, 13.7; IR (KBr) υ: 3033,
2972, 2921, 2876, 1712, 1607, 1486, 1436, 1372, 1282, 1193, 1111,
1025, 862, 816, 742, 700 cm–1; MS (m/z): HRMS (ESI) calcd for C35H40NO3 ([M + H]+): 522.3008. Found: 522.3031.

Ethyl 1′-benzyl-5′-chloro-3,4-(diphenyl)-2′-oxospiro[cyclohexane-1,3′-indolin]-3-ene-6-carboxylate
(2e)
White solid, 83%, 0.227 g, mp 154–156
°C; 1H NMR (400 MHz, CDCl3) δ: 7.38
(s, 1H, ArH), 7.33–7.29 (m, 4H, ArH), 7.25–7.22 (m,
1H, ArH), 7.20–7.18 (m, 2H, ArH), 7.14–7.12 (m, 3H,
ArH), 7.10–7.05 (m, 3H, ArH), 6.93–6.90 (m, 2H, ArH),
6.69 (d, J = 8.0 Hz, 1H, ArH), 5.08 (d, J = 15.6 Hz, 1H, CH), 4.87 (d, J = 15.6 Hz, 1H, ArH),
4.00–3.89 (m, 2H, CH), 3.68 (dd, J1 = 11.6 Hz, J2 = 6.8 Hz, 1H, CH), 3.30–3.21
(m, 2H, CH), 3.09–3.02 (m, 1H, CH), 2.36 (d, J = 17.2 Hz, 1H, CH), 1.04 (t, J = 7.2 Hz, 3H, CH3); 13C NMR (100 MHz, CDCl3) δ:
179.1, 171.4, 141.7, 141.5, 141.4, 135.5, 133.6, 133.5, 132.5, 128.8,
128.8, 128.1, 127.9, 127.8, 127.8, 127.6, 127.2, 126.7, 126.5, 124.3,
110.0, 60.8, 48.0, 44.6, 44.2, 41.9, 31.9, 13.9; IR (KBr) υ:
3029, 2985, 2921, 1712, 1607, 1483, 1429, 1352, 1276, 1209, 1110,
1025, 947, 869, 825, 741 cm–1; MS (m/z): HRMS (ESI) calcd for C35H31ClNO3 ([M + H]+): 548.1992. Found: 548.1979.

Ethyl 5′-chloro-3,4-(diphenyl)-2′-oxospiro[cyclohexane-1,3′-indolin]-3-ene-6-carboxylate
(2f)
White solid, 77%, 0.175 g, mp 145–147
°C; 1H NMR (400 MHz, CDCl3) δ: 8.31
(s, 1H, NH), 7.35 (s, 1H, ArH), 7.26–7.21 (m, 3H, ArH), 7.17–7.12
(m, 4H, ArH), 7.09–7.04 (m, 3H, ArH), 6.92–6.89 (m,
3H, ArH), 4.05–3.95 (m, 2H, CH), 3.62–3.57 (m, 1H, CH),
3.26–3.17 (m, 2H, CH), 3.06–2.99 (m, 1H, CH), 2.40 (d, J = 18.0 Hz, 1H, CH), 1.10 (t, J = 7.2
Hz, 3H, CH3); 13C NMR (100 MHz, CDCl3) δ: 181.4, 171.4, 141.3, 139.7, 133.8, 133.5, 132.3, 128.8,
128.1, 128.0, 127.9, 127.6, 126.7, 126.5, 124.5, 110.8, 61.0, 48.7,
44.5, 41.5, 31.6, 13.8; IR (KBr) υ: 1715, 1605, 1486, 1431,
1355, 1277, 1211, 1109, 1027, 945, 869, 841, 745 cm–1; MS (m/z): HRMS (ESI) calcd for
C28H24ClNNaO3 ([M + Na]+): 480.1342. Found: 480.1331.

Ethyl 3,4-(bis-4-methylphenyl)-2′-oxospiro[cyclohexane-1,3′-indolin]-3-ene-6-carboxylate
(2g)
White solid, 80%, 0.180 g, mp 160–162
°C; 1H NMR (400 MHz, CDCl3) δ: 8.03
(s, 1H, NH), 7.36–7.35 (m, 1H, ArH), 7.26–7.22 (m, 1H,
ArH), 7.02 (brs, 5H, ArH), 6.95–6.93 (m, 1H, ArH), 6.88–6.87
(m, 2H, ArH), 6.81–6.79 (m, 2H, ArH), 3.98–3.93 (m,
2H, CH), 3.56–3.54 (m, 1H, CH), 3.18–3.14 (m, 2H, CH),
3.07–2.99 (m, 1H, CH), 2.37 (d, J = 16.4 Hz,
1H, CH), 2.28 (s, 3H, CH3), 2.20 (s, 3H, CH3), 1.05 (brs, 3H, CH3); 13C NMR (100 MHz, CDCl3) δ: 181.8, 171.6, 141.1, 138.9, 138.8, 136.0, 135.8,
132.7, 132.1, 131.9, 128.7, 128.7, 128.5, 128.0, 124.1, 122.4, 109.9,
60.7, 48.6, 44.5, 41.8, 31.7, 21.1, 21.0, 13.8; IR (KBr) υ:
3033, 2987, 2923, 1711, 1609, 1487, 1434, 1354, 1278, 1215, 1116,
1032, 948, 869, 817, 747, 710 cm–1; MS (m/z): HRMS (ESI) calcd for C30H29NNaO3 ([M + Na]+): 474.2045.
Found: 474.2035.

6-Phenyl-3,4-(bis-p-methyl-phenyl)-spiro[cyclohexane-1,2′-inden]-3-ene-1′,3′-dione
(3a)
White solid, 54%, 0.126 g, mp 197–199
°C; 1H NMR (400 MHz, CDCl3) δ: 7.86
(d, J = 7.2 Hz, 1H, ArH), 7.70–7.66 (m, 2H,
ArH), 7.62–7.59 (m, 1H, ArH), 7.10–7.08 (m, 2H, ArH),
7.05–7.00 (m, 4H, ArH), 6.96–6.94 (m, 6H, ArH), 3.73–3.69
(m, 1H, CH), 3.56–3.48 (m, 1H, CH), 3.16 (d, J = 17.6 Hz, 1H, CH), 2.79–2.74 (m, 1H, CH), 2.50 (d, J = 18.0 Hz, 1H, CH), 2.25–2.20 (m, 6H, 2CH3); 13C NMR (100 MHz, CDCl3) δ: 203.5,
202.7, 142.2, 141.2, 139.6, 139.3, 135.5, 135.5, 135.4, 135.1, 134.7,
129.9, 128.9, 128.8, 128.5, 128.4, 128.3, 128.3, 128.3, 128.1, 127.0,
122.8, 122.6, 57.2, 45.3, 37.6, 36.0, 21.0; IR (KBr) υ: 1738,
1703, 1594, 1504, 1453, 1342, 1244, 1103, 1034, 946, 816, 759 cm–1; MS (m/z): HRMS
(ESI) calcd for C34H28NaO2 ([M +
Na]+): 491.1987. Found: 491.1991.

6-(p-Methylphenyl)-3,4-(bis-4-methylphenyl)-spiro[cyclohexane-1,2′-inden]-3-ene-1′,3′-dione
(3b)
White solid, 58%, 0.140 g, mp 211–213
°C; 1H NMR (400 MHz, CDCl3) δ: 7.87
(d, J = 6.4 Hz, 1H, ArH), 7.69–7.68 (m, 2H,
ArH), 7.63 (d, J = 6.4 Hz, 1H, ArH), 7.04–7.03
(m, 2H, ArH), 6.96–6.92 (m, 8H, ArH), 6.83–6.81 (m,
2H, ArH), 3.53–3.46 (m, 1H, CH), 3.14 (d, J = 17.6 Hz, 1H, CH), 2.74 (d, J = 16.8 Hz, 1H, CH),
2.49 (d, J = 18.0 Hz, 1H, CH), 2.24–2.22 (s,
6H, 2CH3), 2.10 (s, 3H, CH3); 13C
NMR (100 MHz, CDCl3) δ: 203.6, 202.8, 142.1, 141.3,
139.6, 139.3, 136.6, 136.4, 135.4, 135.4, 135.0, 134.9, 129.9, 128.9,
128.8, 128.4, 128.4, 128.1, 122.8, 122.6, 57.2, 44.8, 37.8, 36.2,
21.0, 21.0, 20.8; IR (KBr) υ: 1737, 1703, 1594, 1509, 1432,
1347, 1243, 1108, 1036, 953, 912, 814 cm–1; MS (m/z): HRMS (ESI) calcd for C35H30NaO2 ([M + Na]+): 505.2143. Found:
505.2149.

6-(p-Methoxyphenyl)-3,4-(diphenyl)-spiro[cyclohexane-1,2′-inden]-3-ene-1′,3′-dione
(3c)
White solid, 62%, 0.146 g, mp 216–218
°C; 1H NMR (400 MHz, CDCl3) δ: 7.87
(d, J = 7.6 Hz, 1H, ArH), 7.70–7.68 (m, 2H,
ArH), 7.65–7.61 (m, 1H, ArH), 7.14–7.13 (m, 4H, ArH),
7.09–7.01 (m, 8H, ArH), 6.56 (d, J = 8.4 Hz,
1H, ArH), 3.69 (dd, J1 = 8.0 Hz, J2 = 4.4 Hz, 1H, CH), 3.62 (s, 3H, OCH3), 3.55–3.48 (m, 1H, CH), 3.18 (d, J = 18.0
Hz, 1H, CH), 2.76 (dd, J1 = 18.0 Hz, J2 = 4.0 Hz, 1H, CH), 2.52 (d, J = 18.0 Hz, 1H, CH); 13C NMR (100 MHz, CDCl3) δ: 203.6, 202.9, 158.3, 142.4, 142.1, 142.1, 141.3, 135.4,
135.2, 131.5, 130.5, 129.3, 129.0, 129.0, 127.7, 127.6, 126.1, 126.0,
122.8, 122.6, 113.5, 57.2, 55.0, 44.3, 37.5, 36.1; IR (KBr) υ:
1735, 1701, 1598, 1508, 1433, 1347, 1253, 1175, 1117, 1073, 1031,
954, 877, 831, 799, 764 cm–1; MS (m/z): HRMS (ESI) calcd for C33H26NaO3 ([M + Na]+): 493.1780. Found: 493.1786.

6-(p-Nitrophenyl)-3,4-(diphenyl)-spiro[cyclohexane-1,2′-inden]-3-ene-1′,3′-dione
(3d)
White solid, 52%, 0.126 g, mp 242–244
°C; 1H NMR (400 MHz, CDCl3) δ: 7.93–7.91
(m, 3H, ArH), 7.78–7.74 (m, 1H, ArH), 7.73–7.69 (m,
2H, ArH), 7.33–7.31 (m, 2H, ArH), 7.18–7.13 (m, 4H,
ArH), 7.11–7.08 (m, 3H, ArH), 7.06–7.02 (m, 3H, ArH),
3.88 (dd, J1 = 12.0 Hz, J2 = 5.2 Hz, 1H, CH), 3.19 (d, J = 18.0
Hz, 1H, CH), 2.82 (dd, J1 = 17.6 Hz, J2 = 5.2 Hz, 1H, CH), 2.57 (d, J = 18.0 Hz, 1H, CH); 13C NMR (100 MHz, CDCl3) δ: 202.6, 201.9, 147.4, 146.9, 141.9, 141.7, 141.6, 140.8,
136.1, 135.7, 134.8, 130.6, 129.3, 128.9, 128.9, 127.8, 126.3, 123.4,
123.1, 123.0, 56.6, 44.6, 37.8, 35.5; IR (KBr) υ: 1739, 1701,
1594, 1514, 1430, 1341, 1247, 1172, 1107, 1016, 954, 851, 799, 759
cm–1; MS (m/z):
HRMS (ESI) calcd for C32H23NNaO4 ([M
+ Na]+): 508.1525. Found: 508.1531.

6-(p-Nitro-phenyl)-3,4-(bis-p-methyl-phenyl)-spiro[cyclohexane-1,2′-inden]-3-ene-1′,3′-dione
(3e)
White solid, 59%, 0.151 g, mp 247–249
°C; 1H NMR (400 MHz, CDCl3) δ: 7.93–7.89
(m, 3H, ArH), 7.77–7.73 (m, 1H, ArH), 7.72–7.68 (m,
2H, ArH), 7.32–7.29 (m, 2H, ArH), 7.05–7.03 (m, 2H,
ArH), 6.98–6.96 (m, 2H, ArH), 6.92 (brs, 4H, ArH), 3.85 (dd, J1 = 12.0 Hz, J2 =
5.2 Hz, 1H, CH), 3.60–3.52 (m, 1H, CH), 3.15 (d, J = 18.0 Hz, 1H, CH), 2.78 (dd, J1 = 17.6
Hz, J2 = 5.2 Hz, 1H, CH), 2.54 (d, J = 18.0 Hz, 1H, CH), 2.26 (s, 3H, CH3), 2.22
(s, 3H, CH3); 13C NMR (100 MHz, CDCl3) δ: 202.7, 201.8, 147.5, 146.9, 141.7, 140.8, 139.1, 138.8,
136.0, 135.8, 135.8, 135.7, 134.2, 130.0, 129.3, 128.8, 128.7, 128.5,
123.4, 123.1, 123.0, 56.7, 44.6, 38.0, 35.6, 21.0, 21.0; IR (KBr)
υ: 1741, 1701, 1599, 1518, 1431, 1345, 1244, 1175, 1108, 1028,
957, 908, 817 cm–1; MS (m/z): HRMS (ESI) calcd for C34H27NNaO3 ([M + Na]+): 536.1838. Found: 536.1837.

6-(p-Bromo-phenyl)-3,4-(diphenyl)-spiro[cyclohexane-1,2′-inden]-3-ene-1′,3′-dione
(3f)
White solid, 48%, 0.124 g, mp 209–211
°C; 1H NMR (400 MHz, CDCl3) δ: 7.89
(d, J = 7.6 Hz, 1H, ArH), 7.76–7.68 (m, 3H,
ArH), 7.18–7.13 (m, 6H, ArH), 7.10–7.04 (m, 5H, ArH),
7.02–6.99 (m, 3H, ArH), 3.71 (dd, J1 = 8.4 Hz, J2 = 4.8 Hz, 1H, CH), 3.56–3.48
(m, 1H, CH), 3.17 (d, J = 18.8 Hz, 1H, CH), 2.77
(dd, J1 = 17.6 Hz, J2 = 4.4 Hz, 1H, CH), 2.53 (d, J = 18.0 Hz,
1H, CH); 13C NMR (100 MHz, CDCl3) δ: 203.1,
202.4, 142.2, 141.9, 141.9, 141.1, 138.7, 135.7, 135.4, 135.2, 131.3,
130.5, 130.0, 129.0, 128.9, 127.7, 127.7, 126.2, 126.2, 123.0, 122.8,
121.0, 56.8, 44.4, 37.7, 35.8; IR (KBr) υ: 1737, 1702, 1591,
1486, 1415, 1345, 1245, 1165, 1073, 1004, 957, 876, 828, 797, 763
cm–1; MS (m/z):
HRMS (ESI) calcd for C32H23BrNaO2 ([M + Na]+): 541.0779. Found: 541.0787.

6-(m-Chloro-phenyl)-3,4-(bis-4-methylphenyl)-spiro[cyclohexane-1,2′-inden]-3-ene-1′,3′-dione
(3g)
White solid, 56%, 0.140 g, mp 183–185
°C; 1H NMR (400 MHz, CDCl3) δ: 7.96
(d, J = 7.6 Hz, 1H, ArH), 7.78–7.75 (m, 2H,
ArH), 7.70–7.67 (m, 1H, ArH), 7.25–7.23 (m, 1H, ArH),
7.12 (d, J = 7.6 Hz, 1H, ArH), 7.05–7.03 (m,
2H, ArH), 6.96–6.90 (m, 7H, ArH), 6.89–6.86 (m, 1H,
ArH), 4.42 (dd, J1 = 10.8 Hz, J2 = 5.6 Hz, 1H, CH), 3.30–3.23 (m, 1H,
CH), 3.15 (d, J = 18.4 Hz, 1H, CH), 2.81 (dd, J1 = 17.6 Hz, J2 =
5.2 Hz, 1H, CH), 2.54 (d, J = 18.0 Hz, 1H, CH), 2.24
(s, 3H, CH3), 2.20 (s, 3H, CH3); 13C NMR (100 MHz, CDCl3) δ: 202.7, 202.0, 142.1, 141.1,
139.3, 139.2, 138.0, 135.6, 135.5, 135.3, 134.9, 134.2, 130.0, 129.9,
128.8, 128.7, 128.5, 128.4, 128.0, 127.9, 126.7, 123.1, 122.9, 56.1,
40.1, 38.2, 36.9, 21.0, 21.0; IR (KBr) υ: 1739, 1703, 1594,
1509, 1433, 1347, 1243, 1108, 1036, 952, 815, 728 cm–1; MS (m/z): HRMS (ESI) calcd for
C34H27ClNaO2 ([M + Na]+): 525.1597. Found: 525.1599.

6-(o-Chloro-phenyl)-3,4-(bis-p-methyl-phenyl)-spiro[cyclohexane-1,2′-inden]-3-ene-1′,3′-dione
(3h)
White solid, 51%, 0.128 g, mp 159–161
°C; 1H NMR (400 MHz, CDCl3) δ: 7.96
(d, J = 7.6 Hz, 1H, ArH), 7.78–7.75 (m, 2H,
ArH), 7.71–7.67 (m, 1H, ArH), 7.25–7.23 (m, 1H, ArH),
7.12 (d, J = 7.6 Hz, 1H, ArH), 7.04 (d, J = 7.6 Hz, 1H, ArH), 6.96–6.86 (m, 8H, ArH), 4.44–4.40
(m, 1H, CH), 3.30–3.23 (m, 1H, CH), 3.15 (d, J = 17.6 Hz, 1H, CH), 2.81 (dd, J1 = 17.6
Hz, J2 = 4.8 Hz, 1H, CH), 2.54 (d, J = 18.0 Hz, 1H, CH), 2.25–2.22 (m, 6H, 2CH3); 13C NMR (100 MHz, CDCl3) δ: 202.7,
202.0, 142.1, 141.1, 139.3, 139.2, 138.0, 135.6, 135.5, 135.3, 134.9,
134.2, 130.0, 129.9, 128.8, 128.8, 128.5, 128.4, 128.0, 127.9, 126.7,
123.1, 122.9, 56.1, 40.1, 38.2, 36.9, 21.0, 21.0; IR (KBr) υ:
1738, 1703, 1594, 1509, 1469, 1433, 1351, 1243, 1104, 1037, 954, 815,
753 cm–1; MS (m/z): HRMS (ESI) calcd for C34H27ClNaO2 ([M + Na]+): 525.1597. Found: 525.1603.

Supporting Information Available
The Supporting
Information
is available free of charge on the ACS Publications website at DOI: 10.1021/acsomega.8b00464.1H
and 13C NMR spectra for all
pure products (PDF)

X-ray crystal data for 1a (CCDC 1819872), 1g (CCDC 1819873), 1h (CCDC 1819874), 2b (CCDC 1819875), 3d (CCDC 1819876) (CIF)



Supplementary Material
ao8b00464_si_001.pdf

 ao8b00464_si_002.cif

 The authors
declare no competing financial interest.

Acknowledgments
This work
was financially supported by the National Natural
Science Foundation of China (Grant No. 21572196) and the Priority
Academic Program Development of Jiangsu Higher Education Institutions.
We also acknowledge the Analysis and Test Center of Yangzhou University
for providing instruments for analysis.
==== Refs
References
a Tang Y.-Q ; Sattler I. ; Thiericke R. ; Grabley S. ; Feng X.-Z 
Maremycins
C and D, new diketopiperazines,
and maremycins E and F, novel polycyclic spiro-indole metabolites
isolated from Streptomyces . Eur. J. Org. Chem. 
2001 , 2 , 261 –267 . b Sudhapriya N. ; Perumal P. T. ; Balachandran C. ; Ignacimuthu S. ; Sangeetha M. ; Doble M. 
Synthesis of new class
of spirocarbocycle derivatives by multicomponent domino reaction and
their evaluation for antimicrobial, anticancer activity and molecular
docking studies . Eur. J. Med. Chem. 
2014 , 83 , 190 –207 . 10.1016/j.ejmech.2014.05.065 .24956555  c Davis H. J. ; Kavanagh M. E. ; Balan T. ; Abell C. ; Coyne A. G. 
Spirooxindoles
as novel 3D-fragment scaffolds: Synthesis and screening against CYP121
from M. Tuberculosis . Bioorg. Med. Chem. Lett. 
2016 , 26 , 3735 –3740 . 10.1016/j.bmcl.2016.05.073 .27287372  d Zhang L. D. ; Ren W. ; Wang X. Y. ; Zhang J. Y. ; Liu J. ; Zhao L. F. ; Zhang X. 
Discovery of novel polycyclic spiro-fused
carbocyclic oxindole-based anticancer agents . Eur. J. Med. Chem. 
2017 , 126 , 1071 –1082 . 10.1016/j.ejmech.2016.12.021 .28027532 
a Wu Y.-E. ; Li Y.-D. ; Luo Y.-J. ; Wang T.-X. ; Wang H.-J. ; Chen S.-N. ; Qu W.-M. ; Huang Z.-L. 
Gelsemine
alleviates both neuropathic pain and sleep disturbance in partial
sciatic nerve ligation mice . Acta Pharmacol.
Sin. 
2015 , 36 , 1308 –1317 . 10.1038/aps.2015.86 .26388157  b Aronson D. ; Verbalis J. G. ; Mueller M. ; Krum H. ; Alvarisqueta A. ; Blueguermann J. ; Guerrero R. A. ; Ahuad H. L. ; Krum H. ; Sindone A. 
Short- and long-term treatment of
dilutional hyponatremia with satavaptan, a selective arginine vasopressin
V2-receptor antagonist: the DILIPO study . Eur.
J. Heart Failure 
2011 , 13 , 327 –336 . 10.1093/eurjhf/hfq226 . c Rottmann M. ; McNamara C. ; Yeung B. K. S. ; Lee M. C. S. ; Zou B. ; Russell B. ; Seitz P. ; Plouffe D. M. ; Dharia N. V. ; Tan J. ; Cohen S. B. ; Spencer K. R. ; González-Páez G. E. ; Lakshminarayana S. B. ; Goh A. ; Suwanarusk R. ; Jegla T. ; Schmitt E. K. ; Beck H. ; Brun R. ; Nosten F. ; Renia L. ; Dartois V. ; Keller T. H. ; Fidock D. A. ; Winzeler E. A. ; Diagana T. T. 
Spiroindolones,
a Potent Compound Class for the Treatment of Malaria . Science 
2010 , 329 , 1175 –1180 . 10.1126/science.1193225 .20813948 
a Kotha S. B. ; Deb A. C. ; Lahiri K. ; Manivannan E. 
Selected synthetic
strategies to spirocyclics . Synthesis 
2009 , 2009 , 165 –193 . 10.1055/s-0028-1083300 . b Trost B. M. ; Brennan M. K. 
Asymmetric syntheses of oxindole and indole spirocyclic
alkaloid natural products . Synthesis 
2009 , 2009 , 3003 –3025 . 10.1055/s-0029-1216975 . c Ball-Jones N. R. ; Badillo J. J. ; Franz A. K. 
Strategies for the enantioselective
synthesis of spirooxindoles . Org. Biomol. Chem. 
2012 , 10 , 5165 –5181 . 10.1039/c2ob25184a .22581310  d Singh G. S. ; Desta Z. Y. 
Isatins As Privileged Molecules in Design and Synthesis
of Spiro-Fused Cyclic Frameworks . Chem. Rev. 
2012 , 112 , 6104 –6155 . 10.1021/cr300135y .22950860 
a Hong L. ; Wang R. 
Recent Advances in Asymmetric Organocatalytic
Construction of 3,3′-Spirocyclic Oxindoles . Adv. Synth. Catal. 
2013 , 355 , 1023 –1030 . 10.1002/adsc.201200808 . b Liu Y. Y. ; Wang H. ; Wan J. P. 
Recent
Advances in Diversity Oriented Synthesis through Isatin-based Multicomponent
Reactions . Asian J. Org. Chem. 
2013 , 2 , 374 –386 . 10.1002/ajoc.201200180 . c Liu Z.-M. ; Li N.-K. ; Huang X.-F. ; et al. Asymmetric organocatalytic
conjugate addition of dialkyl phosphites to N-unprotected isatylidene malononitriles: access
to 3-phospho-2-oxindoles with chiral quaternary stereocenters . Tetrahedron 
2014 , 70 , 2406 –2415 . 10.1016/j.tet.2014.02.023 . d Cheng D. Q. ; Ishihara Y. ; Tan B. ; Barbas C. F. III
Organocatalytic Asymmetric Assembly Reactions: Synthesis
of Spirooxindoles via Organocascade Strategies . ACS Catal. 
2014 , 4 , 743 –762 . 10.1021/cs401172r .
a Zeng X. ; Ni Q. J. ; Raabe G. ; Enders D. 
A branched
domino reaction: asymmetric organocatalytic two-component four-step
synthesis of polyfunctionalized cyclohexene derivatives . Angew. Chem., Int. Ed. 
2013 , 52 , 2977 –2980 . 10.1002/anie.201209581 . b Xu S. ; Li C. J. ; Jia X. S. ; Li J. 
AlCl3-Promoted Selective Michael Addition with Allenoate
and Methyleneindolinone: Synthesis of Spirocyclic Oxindole by Using
Allenoate as a Four-Carbon Component Building Block . J. Org. Chem. 
2014 , 79 , 11161 –11169 . 10.1021/jo502209f .25347308  c Ghosh A. K. ; Zhou B. 
Enantioselective synthesis
of spiro[cyclohexane-1,3′-indolin]-2′-ones containing
multiple stereocenters via organocatalytic Michael/aldol cascade reactions . Tetrahedron Lett. 
2013 , 54 , 2311 –2314 . 10.1016/j.tetlet.2013.02.030 .25705059  d Lu Y.
L. ; Sun J. ; Xie Y. J. ; Yan C. G. 
Molecular diversity of the cyclization
reaction of 3-methyleneoxindoles with 2-(3,4-dihydronaphthalen-1(2H)-ylidene)malononitriles . RSC Adv. 
2016 , 6 , 23390 –23395 . 10.1039/C6RA00476H .
Rossi E. ; Abbiati E. G. ; Pirovano V. 
2- and 3-Vinylindoles
as 4π
Components in Cycloaddition Reactions . Eur.
J. Org. Chem. 
2017 , 2017 , 4512 –4529 . 10.1002/ejoc.201700120 .
a Okada K. ; Kondo M. ; Tanino H. ; Kakoi H. ; Inoue S. 
On the structure of the Diels-Alder
adducts obtained from (E)-3-methoxycarbonylmethylene-2-oxoindoline
with unsymmetrical
butadiene derivatives . Heterocycles 
1992 , 34 , 589 –97 . 10.3987/COM-91-5952 . b Okada K. ; Mizuno Y. ; Tanino H. ; Kakoi H. ; Inoue S. 
Second Approach
to the Construction of a Pentacyclic Ring System for Neosurugatoxin . Chem. Pharm. Bull. 
1992 , 40 , 1110 –1115 . 10.1248/cpb.40.1110 .
a Tan B. ; Hernandez-Torres G. ; Barbas C. F. 
Highly Efficient
Hydrogen-Bonding Catalysis of the Diels-Alder Reaction of 3-Vinylindoles
and Methyleneindolinones Provides Carbazolespirooxindole Skeletons . J. Am. Chem. Soc. 
2011 , 133 , 12354 –12357 . 10.1021/ja203812h .21780763  b Ren J. W. ; Wang J. ; Xiao J. A. ; Li J. ; Xiang H. Y. ; Chen X. Q. ; Yang H. 
L-Pyroglutamic Sulphonamide
as Hydrogen-Bonding Organocatalyst: Enantioselective Diels-Alder Cyclization
to Construct Carbazolespirooxindoles . J. Org.
Chem. 
2017 , 82 , 6441 –6449 . 10.1021/acs.joc.7b00733 .28558239  c Zheng H. ; He P. ; Liu Y. B. ; Zhang Y. L. ; Liu X. H. ; Lin L. L. ; Feng X. M. 
Efficient synthesis
of carbazolespirooxindole skeletons via asymmetric Diels-Alder reaction
of 3-vinylindoles and methyleneindolinones . Chem. Commun. 
2014 , 50 , 8794 –8796 . 10.1039/C4CC03135K . d Wang Y. ; Tu M. S. ; Yin L. ; Sun M. ; Shi F. 
Bronsted Acid Catalyzed Asymmetric Diels-Alder Reactions: Stereoselective
Construction of Spiro[tetrahydrocarbazole-3,3′-oxindole] Framework . J. Org. Chem. 
2015 , 80 , 3223 –3232 . 10.1021/acs.joc.5b00198 .25692214  e Sharma P. ; Kumar N. P. ; Krishna N. H. ; Prasanna D. ; Sridhar B. ; Shankaraiah N. 
Silver(I)-catalysed
domino alkyne-annulation/Diels-Alder reaction: a mild synthetic approach
to tetrahydrospiro[carbazole-4,3′-indoline] scaffolds . Org. Chem. Front. 
2016 , 3 , 1503 –1508 . 10.1039/C6QO00430J .
a Liu Y. ; Nappi M. ; Arceo E. ; Vera S. ; Melchiorre P. 
Asymmetric
Catalysis of Diels-Alder Reactions with
in Situ Generated Heterocyclic ortho-Quinodimethanes . J. Am. Chem. Soc. 
2011 , 133 , 15212 –15218 . 10.1021/ja206517s .21842900  b Bencivenni G. ; Wu L. Y. ; Mazzanti A. ; Giannichi B. ; Pesciaioli F. ; Song M. P. ; Bartoli G. ; Melchiorre P. 
Targeting
Structural and Stereochemical Complexity by Organocascade Catalysis:
Construction of Spirocyclic Oxindoles Having Multiple Stereocenters . Angew. Chem., Int. Ed. 
2009 , 48 , 7200 –7203 . 10.1002/anie.200903192 . c Chatterjee I. ; Bastida D. ; Melchiorre P. 
Vinylogous Organocatalytic Triple Cascade Reaction:
Forging Six Stereocenters in Complex Spiro-Oxindolic Cyclohexanes . Adv. Synth. Catal. 
2013 , 355 , 3124 –3130 . 10.1002/adsc.201300667 .
a Jiang K. ; Jia Z. J. ; Yin X. ; Wu L. ; Chen Y. C. 
Asymmetric Quadruple Aminocatalytic Domino Reactions
to Fused Carbocycles Incorporating a Spirooxindole Motif . Org. Lett. 
2010 , 12 , 2766 –2769 . 10.1021/ol100857s .20481511  b Jiang K. ; Jia Z. J. ; Chen S. ; Wu L. ; Chen Y. C. 
Organocatalytic Tandem Reaction to Construct Six-Membered
Spirocyclic Oxindoles with Multiple Chiral Centres through a Formal
[2 + 2 + 2] Annulation . Chem. - Eur. J. 
2010 , 16 , 2852 –2856 . 10.1002/chem.200903009 .20112315  c Yuan X. ; Zhang S. J. ; Du W. ; Chen Y. C. 
Asymmetric
Diels-Alder Cycloadditions of Trifluoromethylated Dienophiles Under
Trienamine Catalysis . Chem. - Eur. J. 
2016 , 22 , 11048 –11052 . 10.1002/chem.201600989 .27305465 
a Halskov K. S. ; Johansen T. K. ; Davis R. L. ; Steurer M. ; Jensen F. ; Joergensen K. A. 
Cross-trienamines
in Asymmetric Organocatalysis . J. Am. Chem.
Soc. 
2012 , 134 , 12943 –12946 . 10.1021/ja3068269 .22835208  b Jia Z. J. ; Jiang H. ; Li J. L. ; Gschwend B. ; Li Q. Z. ; Yin X. ; Grouleff J. ; Chen Y. C. ; Jorgensen K. A. 
Trienamines in Asymmetric Organocatalysis: Diels-Alder
and Tandem Reactions . J. Am. Chem. Soc. 
2011 , 133 , 5053 –5061 . 10.1021/ja1112194 .21405125 
Wei Q. ; Gong L. Z. 
Organocatalytic Asymmetric Formal [4 + 2] Cycloaddition
for the Synthesis of Spiro[4-cyclohexanone-1,3′-oxindoline]
Derivatives in High Optical Purity . Org. Lett. 
2010 , 12 , 1008 –1011 . 10.1021/ol100020v .20131823 
Yang R.-Y ; Sun J. ; Tao Y. ; Yan C.-G ; et al. TfOH-Catalyzed One-Pot
Domino Reaction for Diastereoselective Synthesis of Polysubstituted
Tetrahydrospiro[carbazole-1,3′-indoline]s . J. Org. Chem. 
2017 , 82 , 13277 –13287 . 10.1021/acs.joc.7b02397 .29131626 
a Lepage L. ; Lepage Y. 
Carbocyclizations and
heterocyclizations of ortho-dibenzyl derivatives
by the effect of sulfur . J. Heterocycl. Chem. 
1978 , 15 , 1185 –1191 . 10.1002/jhet.5570150722 . b Wagner R. A. ; Brinker U. H. 
A novel and facile synthesis of 2,3-diphenylbuta-1,3-diene . Synthesis 
2001 , 0376 –0378 . 10.1055/s-2001-11448 . c Polevaya I. S. ; Fedevich M. D. ; Polyuzhin I. P. ; Marshalok O. I. 
Optimization of synthesis conditions of 2,3-dimethylbutadiene . Russ. J. Appl. Chem. 
2011 , 84 , 261 –265 . 10.1134/S1070427211020169 . d Kostiv I. ; Polyuzhin I. ; Vytrykush N. ; Marshalok G. ; Yatchyshyn J. 
Optimization of 2,3-dimethylbuta-1,3-diene and
2-hydroxyethyl methacrylate cyclization reaction conditions . Chem. Chem. Tech. 
2014 , 8 , 35 –40 .
a Stalpaert M. ; Cirujano F. G. ; De Vos D. E. 
Tetrabutylphosphonium
Bromide Catalyzed Dehydration of Diols to Dienes and Its Application
in the Biobased Production of Butadiene . ACS
Catal. 
2017 , 7 , 5802 –5809 . 10.1021/acscatal.7b01765 . b Hu Y. ; Li N. ; Li G. Y. ; Wang A. Q. ; Cong Y. ; Wang X. D. ; Zhang T. 
Sustainable Production
of o-Xylene from Biomass-Derived Pinacol and Acrolein . ChemSusChem 
2017 , 10 , 2880 –2885 . 10.1002/cssc.201700823 .28621498  c Hu Y. ; Li N. ; Li G. Y. ; Wang A. Q. ; Cong Y. ; Wang X. D. ; Zhang T. 
Solid Acid-Catalyzed
Dehydration of Pinacol Derivatives in Ionic Liquid: Simple and Efficient
Access to Branched 1,3-Dienes . ACS Catal. 
2017 , 7 , 2576 –2582 . 10.1021/acscatal.7b00066 . d Hu Y. ; Li N. ; Li G. Y. ; Wang A. Q. ; Cong Y. ; Wang X. D. ; Zhang T. 
Sustainable production of pyromellitic
acid with pinacol and diethyl maleate . Green
Chem. 
2017 , 19 , 1663 –1667 . 10.1039/C6GC03576K .
Reddy B. V. S. ; Rajeswari N. ; Sarangapani M. ; Reddy G. R. ; Madan C. ; Kumar K. P. ; Rao M. S. 
Iodine-catalyzed conjugate addition
of indoles onto en-1,4-dione. A novel synthesis of 3-(1-(1H-indol-3-yl)-2-oxo-2-phenylethyl)indolin-2-ones
as antibacterial and antifungal agents . Bioorg.
Med. Chem. Lett. 
2011 , 21 , 6510 –6514 . 10.1016/j.bmcl.2011.08.075 .21924612

